Micro Interventional Devices
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5 Caufield Pl # 102, Newtown, Pennsylvan...Phone Number
(215) 600-1270Website
www.microinterventional.comRevenue
$13.4 MillionIndustry
About Micro Interventional Devices
Micro Interventional Devices (MID) specializes in designing, manufacturing, and commercializing innovative catheter-based technologies aimed at treating structural heart disease. Their flagship product, the MIA-T Percutaneous Tricuspid Annuloplasty System, offers a less invasive alternative to traditional open heart surgery, benefiting patients, surgeons, and healthcare networks alike. MID's technologies focus on improving clinical outcomes, reducing operative time, and enhancing ease of use. The company is committed to advancing Transcatheter Cardiac Repair (TCR) to improve the quality of life for patients.Explore more
Micro Interventional Devices Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Micro Interventional Devices
Compare insights from companies similar to Micro Interventional Devices, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Micro Interventional Devices Tech Stack
A closer look at the technologies used by Micro Interventional Devices
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Micro Interventional Devices
Sign Up For FreeTo access detailed company insights
Micro Interventional Devices (MID) specializes in designing, manufacturing, and commercializing innovative catheter-based technologies aimed at treating structural heart disease. Their flagship product, the MIA-T Percutaneous Tricuspid Annuloplasty System, offers a less invasive alternative to traditional open heart surgery, benefiting patients, su... Read More
